Dr. Noa Sher is Chief Scientific Officer at Minovia Therapeutics. A molecular and cellular biologist by training, she specializes in developing cell therapies for rare diseases, with expertise spanning bioinformatics, translational science, and clinical-stage product innovation. Dr. Sher has led R&D teams in academia and industry, including the design and execution of the first mitochondrial augmentation technology trials for mitochondrial diseases. She holds a PhD in Biochemistry from Hebrew University and performed postdoctoral research at the Whitehead Institute and the Technion.
Past Expert Series Presentations
